Zdrowie i gospodarka · 02/06/2016
FDA Clears Path for Triamcinolone Acetonide Injectable Suspension
The FDA has determined that Triamcinis (a triamcinolone acetonide injectable suspension) 80 mg/mL was not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of abbreviated new drug applications.